Orgovyx and Prostate cancer - a phase IV clinical study of FDA data

Summary:

Prostate cancer is reported as a side effect among people who take Orgovyx (relugolix), especially for people who are 60+ old, have been taking the drug for < 1 month also take Xtandi, and have Narcolepsy.

The phase IV clinical study analyzes which people have Prostate cancer when taking Orgovyx. It is created by eHealthMe based on reports of 7,213 people who have side effects when taking Orgovyx from the FDA, and is updated regularly.

What is Orgovyx?

Orgovyx has active ingredients of relugolix. eHealthMe is studying from 7,216 Orgovyx users. Check the latest studies of Orgovyx.

What is Prostate cancer?

Prostate cancer is found to be associated with 998 drugs and 1,206 conditions by eHealthMe. Check the latest studies of Prostate cancer.

On Aug, 05, 2026

7,213 people reported to have side effects when taking Orgovyx.
Among them, 63 people (0.87%) have Prostate cancer.

Among these 63 people:

How long have people been on Orgovyx when they have Prostate cancer? *

What is the age of people who have Prostate cancer when taking Orgovyx? *

What are other drugs people take besides Orgovyx? *

What are other side effects people have besides Prostate cancer? *

Weakness: 7 people, 11.11%
Prostatic Specific Antigen Increased: 6 people, 9.52%
Hot Flush (sudden feelings of heat): 5 people, 7.94%
Muscle Aches (muscle pain): 5 people, 7.94%
Diarrhea: 5 people, 7.94%
Haemoglobin Decreased: 3 people, 4.76%
Fatigue (feeling of tiredness): 3 people, 4.76%
Joint Pain: 3 people, 4.76%
White Blood Cell Count Decreased: 3 people, 4.76%
Depression: 3 people, 4.76%

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 3.17%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 3.17%
Taste - Impaired: 1 person, 1.59%
Drowsiness: 1 person, 1.59%
Arrhythmias (irregular heartbeat): 1 person, 1.59%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 1 person, 1.59%
Blood Pressure Abnormal: 1 person, 1.59%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 1.59%
Constipation: 1 person, 1.59%
Cystic Fibrosis (disease of the secretary glands): 1 person, 1.59%

* Approximation only. Some reports may have incomplete information.

Do you take Orgovyx and have Prostate cancer?

- Check whether Prostate cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Orgovyx:

Orgovyx (7,216 reports)

Prostate cancer treatments and more:

Prostate cancer (224,100 reports)

Browse all side effects of Orgovyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Prostate cancer:

Prostate cancer (998 drugs)

Browse all the conditions that are associated with Prostate cancer:

Prostate cancer (1,206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on relugolix (the active ingredients of Orgovyx) and Orgovyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.